There are no factors, including duration of therapy, that are known to predict the risk of occurrence or the severity of rash associated with
modafinil or NUVIGIL.
In cases where the time to onset was reported, serious rash occurred 1 day to 2 months after initiation of treatment, but isolated cases of serious dermatologic reactions have been reported with symptoms beginning after prolonged treatment (e.g., 3 months).